Table 3.
Patient-Reported Symptoms on IVR
| Condition treated by target medication for IVR participants | ||||
|
Hypertension n = 335 No. (%) |
Diabetes n = 76 No. (%) |
Depression n = 144 No. (%) |
Insomnia n = 85 No. (%) |
|
| Broad symptom screening | ||||
| Skin rash | 12 (3.6) | 3 (3.9) | 7 (4.9) | 1 (1.2) |
| Memory or confusion | 16 (4.8) | 7 (9.2) | 15 (10.4) | 7 (8.2) |
| Stomach or intestinal problems | 16 (4.8) | 14 (18.4) | 19 (13.2) | 2 (2.4) |
| Problems with sexual function | 15 (4.5) | 6 (7.9) | 16 (11.1) | 5 (5.9) |
| Frequent headaches | 25 (7.5) | 8 (10.5) | 25 (17.4) | 8 (9.4) |
| Dizziness or problems with balance | 35 (10.4) | 5 (6.6) | 26 (18.1) | 8 (9.4) |
| Muscle aches | 41 (12.2) | 12 (15.8) | 23 (16.0) | 10 (11.8) |
| Weight changes | 61 (18.2) | 14 (18.4) | 39 (27.1) | 13 (15.3) |
| Drug-specific symptom screening | ||||
| ACE inhibitors | N = 72 | |||
| New cough | 19 (26.4%) | |||
| Swelling of the face, lips, tongue | 4 (5.6%) | |||
| Beta/calcium channel blockers | N = 132 | |||
| New shortness of breath | 14 (10.6) | |||
| Swelling of the legs | 11 (8.3) | |||
| No. of symptoms reported on broad symptom screen | Burden of symptoms reported by survey completers | |||
|
Hypertension N = 264 No. (%) |
Diabetes N = 58 No. (%) |
Depression N = 117 No. (%) |
Insomnia N = 60 No. (%) |
|
| 0 | 157 (59.5) | 24 (41.4) | 43 (36.8) | 35 (58.3) |
| 1 | 51 (19.3) | 14 (24.1) | 29 (24.8) | 14 (23.3) |
| 2 | 25 (9.5) | 10 (17.2) | 22 (18.8) | 5 (8.3) |
| 3 | 18 (6.8) | 7 (12.1) | 12 (10.3) | 2 (3.3) |
| 4 | 4 (1.5) | 3 (5.2) | 7 (6.0) | 1 (1.7) |
| 5 | 9 (3.4) | 0 | 3 (2.6) | 1 (1.7) |
| 6 | 0 | 0 | 1 (0.9) | 2 (3.3) |